Family · Pharmaceutical analytical standards
Plerixafor
A CXCR4 receptor antagonist that releases blood stem cells from the bone marrow, approved in the United States in 2008 to collect them before autologous transplant in patients with non-Hodgkin lymphoma or multiple myeloma. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?It was born as an anti-HIV drug, since HIV uses CXCR4 to enter cells: the first bicyclam of the family was found by chance as an impurity in a commercial sample of cyclam.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
